1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Nanobiotechnology Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 0-10 nm
  • 1.2.3 10-100 nm
• 1.3 Market by Application
  • 1.3.1 Global Nanobiotechnology Market Share by Application: 2020 VS 2026
  • 1.3.2 Pharmaceuticals
  • 1.3.3 Medical Devices
  • 1.3.4 Medical Research
  • 1.3.5 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Nanobiotechnology Market Perspective (2015-2026)
• 2.2 Global Nanobiotechnology Growth Trends by Regions
  • 2.2.1 Nanobiotechnology Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Nanobiotechnology Historic Market Share by Regions (2015-2020)
  • 2.2.3 Nanobiotechnology Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Nanobiotechnology Players by Market Size
  • 3.1.1 Global Top Nanobiotechnology Players by Revenue (2015-2020)
  • 3.1.2 Global Nanobiotechnology Revenue Market Share by Players (2015-2020)
• 3.2 Global Nanobiotechnology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Nanobiotechnology Revenue
• 3.4 Global Nanobiotechnology Market Concentration Ratio
  • 3.4.1 Global Nanobiotechnology Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Nanobiotechnology Revenue in 2019
• 3.5 Key Players Nanobiotechnology Area Served
• 3.6 Key Players Nanobiotechnology Product Solution and Service
• 3.7 Date of Enter into Nanobiotechnology Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Nanobiotechnology Breakdown Data by Type (2015-2026)

• 4.1 Global Nanobiotechnology Historic Market Size by Type (2015-2020)
• 4.2 Global Nanobiotechnology Forecasted Market Size by Type (2021-2026)

5 Nanobiotechnology Breakdown Data by Application (2015-2026)

• 5.1 Global Nanobiotechnology Historic Market Size by Application (2015-2020)
• 5.2 Global Nanobiotechnology Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Nanobiotechnology Market Size (2015-2026)
• 6.2 North America Nanobiotechnology Market Size by Type (2015-2020)
• 6.3 North America Nanobiotechnology Market Size by Application (2015-2020)
• 6.4 North America Nanobiotechnology Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Nanobiotechnology Market Size (2015-2026)
• 7.2 Europe Nanobiotechnology Market Size by Type (2015-2020)
• 7.3 Europe Nanobiotechnology Market Size by Application (2015-2020)
• 7.4 Europe Nanobiotechnology Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Nanobiotechnology Market Size (2015-2026)
• 8.2 China Nanobiotechnology Market Size by Type (2015-2020)
• 8.3 China Nanobiotechnology Market Size by Application (2015-2020)
• 8.4 China Nanobiotechnology Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Nanobiotechnology Market Size (2015-2026)
• 9.2 Japan Nanobiotechnology Market Size by Type (2015-2020)
• 9.3 Japan Nanobiotechnology Market Size by Application (2015-2020)
• 9.4 Japan Nanobiotechnology Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Nanobiotechnology Market Size (2015-2026)
• 10.2 Southeast Asia Nanobiotechnology Market Size by Type (2015-2020)
• 10.3 Southeast Asia Nanobiotechnology Market Size by Application (2015-2020)
• 10.4 Southeast Asia Nanobiotechnology Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Aduro BioTech
  • 11.1.1 Aduro BioTech Company Details
  • 11.1.2 Aduro BioTech Business Overview
  • 11.1.3 Aduro BioTech Nanobiotechnology Introduction
  • 11.1.4 Aduro BioTech Revenue in Nanobiotechnology Business (2015-2020))
  • 11.1.5 Aduro BioTech Recent Development
• 11.2 Calando Pharmaceuticals
  • 11.2.1 Calando Pharmaceuticals Company Details
  • 11.2.2 Calando Pharmaceuticals Business Overview
  • 11.2.3 Calando Pharmaceuticals Nanobiotechnology Introduction
  • 11.2.4 Calando Pharmaceuticals Revenue in Nanobiotechnology Business (2015-2020)
  • 11.2.5 Calando Pharmaceuticals Recent Development
• 11.3 Biosante Phosphate Pharmaceuticals
  • 11.3.1 Biosante Phosphate Pharmaceuticals Company Details
  • 11.3.2 Biosante Phosphate Pharmaceuticals Business Overview
  • 11.3.3 Biosante Phosphate Pharmaceuticals Nanobiotechnology Introduction
  • 11.3.4 Biosante Phosphate Pharmaceuticals Revenue in Nanobiotechnology Business (2015-2020)
  • 11.3.5 Biosante Phosphate Pharmaceuticals Recent Development
• 11.4 Celgene Corporation
  • 11.4.1 Celgene Corporation Company Details
  • 11.4.2 Celgene Corporation Business Overview
  • 11.4.3 Celgene Corporation Nanobiotechnology Introduction
  • 11.4.4 Celgene Corporation Revenue in Nanobiotechnology Business (2015-2020)
  • 11.4.5 Celgene Corporation Recent Development
• 11.5 Elan Pharmaceuticals
  • 11.5.1 Elan Pharmaceuticals Company Details
  • 11.5.2 Elan Pharmaceuticals Business Overview
  • 11.5.3 Elan Pharmaceuticals Nanobiotechnology Introduction
  • 11.5.4 Elan Pharmaceuticals Revenue in Nanobiotechnology Business (2015-2020)
  • 11.5.5 Elan Pharmaceuticals Recent Development
• 11.6 Flamel Technologies
  • 11.6.1 Flamel Technologies Company Details
  • 11.6.2 Flamel Technologies Business Overview
  • 11.6.3 Flamel Technologies Nanobiotechnology Introduction
  • 11.6.4 Flamel Technologies Revenue in Nanobiotechnology Business (2015-2020)
  • 11.6.5 Flamel Technologies Recent Development
• 11.7 Nanophase Technologies
  • 11.7.1 Nanophase Technologies Company Details
  • 11.7.2 Nanophase Technologies Business Overview
  • 11.7.3 Nanophase Technologies Nanobiotechnology Introduction
  • 11.7.4 Nanophase Technologies Revenue in Nanobiotechnology Business (2015-2020)
  • 11.7.5 Nanophase Technologies Recent Development
• 11.8 Sigma Aldrich Company
  • 11.8.1 Sigma Aldrich Company Company Details
  • 11.8.2 Sigma Aldrich Company Business Overview
  • 11.8.3 Sigma Aldrich Company Nanobiotechnology Introduction
  • 11.8.4 Sigma Aldrich Company Revenue in Nanobiotechnology Business (2015-2020)
  • 11.8.5 Sigma Aldrich Company Recent Development
• 11.9 Dendritic Nanotechnologies
  • 11.9.1 Dendritic Nanotechnologies Company Details
  • 11.9.2 Dendritic Nanotechnologies Business Overview
  • 11.9.3 Dendritic Nanotechnologies Nanobiotechnology Introduction
  • 11.9.4 Dendritic Nanotechnologies Revenue in Nanobiotechnology Business (2015-2020)
  • 11.9.5 Dendritic Nanotechnologies Recent Development
• 11.10 SkyePharma Pharmaceuticals
  • 11.10.1 SkyePharma Pharmaceuticals Company Details
  • 11.10.2 SkyePharma Pharmaceuticals Business Overview
  • 11.10.3 SkyePharma Pharmaceuticals Nanobiotechnology Introduction
  • 11.10.4 SkyePharma Pharmaceuticals Revenue in Nanobiotechnology Business (2015-2020)
  • 11.10.5 SkyePharma Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Nanobiotechnology Scope and Market Size
Nanobiotechnology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nanobiotechnology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
0-10 nm
10-100 nm

Market segment by Application, split into
Pharmaceuticals
Medical Devices
Medical Research
Other

Based on regional and country-level analysis, the Nanobiotechnology market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Nanobiotechnology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Aduro BioTech
Calando Pharmaceuticals
Biosante Phosphate Pharmaceuticals
Celgene Corporation
Elan Pharmaceuticals
Flamel Technologies
Nanophase Technologies
Sigma Aldrich Company
Dendritic Nanotechnologies
SkyePharma Pharmaceuticals